Zacks Investment Research upgraded shares of Aemetis (NASDAQ:AMTX) from a sell rating to a hold rating in a research note published on Monday morning.
According to Zacks, “Aemetis, Inc. is an advanced fuels and renewable chemicals company. It produces renewable chemicals and fuels using patented microbes and processes. Aemetis owns and operates an ethanol animal feed plant in California to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. The Company also built, owns, and operates a renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis, Inc. is headquartered in Cupertino, California. “
Separately, B. Riley reissued a hold rating and issued a $2.00 price objective on shares of Aemetis in a research report on Monday, November 13th.
A hedge fund recently bought a new stake in Aemetis stock. Ninepoint Partners LP purchased a new stake in shares of Aemetis Inc (NASDAQ:AMTX) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 1,151,373 shares of the specialty chemicals company’s stock, valued at approximately $1,002,000. Ninepoint Partners LP owned about 5.81% of Aemetis at the end of the most recent reporting period. 17.73% of the stock is owned by institutional investors and hedge funds.
Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.